|
RSBN1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.244100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.650100E-02 |
| Normal-vs-Stage2 |
4.982600E-01 |
| Normal-vs-Stage3 |
7.636300E-03 |
| Normal-vs-Stage4 |
2.628000E-04 |
| Stage1-vs-Stage2 |
6.433800E-01 |
| Stage1-vs-Stage3 |
3.676800E-01 |
| Stage1-vs-Stage4 |
3.486100E-02 |
| Stage2-vs-Stage3 |
2.688200E-01 |
| Stage2-vs-Stage4 |
8.261700E-02 |
| Stage3-vs-Stage4 |
3.281200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.820330E-02 |
| Normal-vs-AfricanAmerican |
7.016300E-02 |
| Normal-vs-Asian |
1.841750E-02 |
| Caucasian-vs-AfricanAmerican |
9.212600E-01 |
| Caucasian-vs-Asian |
5.644800E-01 |
| AfricanAmerican-vs-Asian |
4.570400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.935800E-03 |
| Normal-vs-Female |
5.707800E-01 |
| Male-vs-Female |
1.626830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.438300E-02 |
| Normal-vs-Extreme_Weight |
1.543870E-02 |
| Normal-vs-Obese |
8.830200E-02 |
| Normal-vs-Extreme_Obese |
1.881640E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.986800E-01 |
| Normal_Weight-vs-Obese |
3.129000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.114600E-01 |
| Extreme_Weight-vs-Obese |
3.800600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.980600E-01 |
| Obese-vs-Extreme_Obese |
4.004600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.640100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.457000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.849100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.157400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.687400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.976600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.160300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.055000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.718000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.852800E-01 |
| Normal-VS-Type2 PRCC |
4.27379999999866E-05 |
| Normal-VS-KIRP CIMP |
1.022000E-01 |
| Normal-VS-Unclassified PRCC |
8.465200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.321600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.350200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.890600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.427400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.260400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.696200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43159999999687E-05 |
| Normal-vs-N1 |
4.158300E-02 |
| Normal-vs-N2 |
2.464300E-03 |
| N0-vs-N1 |
1.432610E-01 |
| N0-vs-N2 |
5.585200E-01 |
| N1-vs-N2 |
1.915380E-01 |
|
|
